iRhythm Technologies (IRTC) PT Lowered to $152 at Canaccord

Canaccord analyst William Plovanic lowered the price target on iRhythm Technologies (NASDAQ: IRTC) to $152.00 (from $180.00) while maintaining a Buy rating.

The analyst commented: "This note reflects a model update for IRTC, as we are correcting an error in our EPS calculations for 2026. Because of this correction, we now model $0.24 of adjusted EPS compared to our previous $0.35. No other changes, including to our $0.90 2027E adjusted EPS estimates were made. We maintain our BUY rating on shares of IRTC, and adjust our PT to $152 from $180, as we remove our previously applied premium."

You May Also Be Interested In

• Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
• Morgan Stanley Upgrades Sonova Holding AG (SOON:SW) (SONVY) to Equalweight
• Texas Capital Securities Downgrades Arcosa (ACA) to Hold